Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial
The fundamental difference is whether GHK-Cu is included
Researchers classify it as a peptide therapy in dubai meaning it produces many different biological effects from a single intervention
Clinical study summary
Mol Aspects Med 30, 1328.CrossRefGoogle ScholarPubMed Bruggeman, BK, Storo, KE, Fair, HM, et al
Anemia can also result in hair loss